EMEA Region
The Eisai EMEA (Europe, Middle East, Africa) region includes many markets including Australia, Austria, Belgium, the Czech Republic/Slovakia, France, Germany, Israel, Italy, the Kingdom of Saudi Arabia, Luxembourg, the Netherlands, New Zealand, the Nordics, Portugal, Russia, Spain, Switzerland and the UK/Ireland. In regions where Eisai EMEA does not have an affiliate, we have entered into partnerships to help relevant patients in these regions access our medicines. Please click on the images below for contact details.
Eisai in the UK
Eisai is very proud to include drug discovery and development research as well as manufacturing to our presence in the UK. Our continued commitment in the UK is demonstrated through an external innovation drug discovery strategy, which includes strategic partnership initiatives and an academic-industrial alliance. Click here for more information.
Our manufacturing plant in Hatfield is the hub of Eisai's production and supply chain, producing tablets, packaging these into blisters, labelling and packaging vials vials and bottles. Click here for more information.
human health care
Our work at Eisai prioritises patients and their families, through our focus to continually improve the benefits that health care can provide.
We call this human health care, (hhc)
FIND OUT MORE
